◆ 基本情况

姓名：施军平，医学博士，主任中医师，教授（博士生导师）

邮箱：20131004@hznu.edu.cn.

专业：内科学

◆ 研究领域

脂肪性肝病与疑难肝脏疾病的临床与基础研究

◆ 主讲课程

1.医学导论

2.内科学

◆ 主持教学科研项目和科研成果

◆ 科研项目

1. 国家科技重大专项课题“代谢相关脂肪性肝病精准干预的数字治疗和新药临床试验”（2023ZD0508704），2024.08-2028.12。

2.浙江省自然科学基金重点项目“肠道微生态调控肝脏中性粒细胞性质和功能转化介导Wilson病发生发展的机制研究”（LHDMZ24H030001），2024.01-2027.12

3.中国高校产学研创新基金“基于血清蛋白组学技术解析非酒精性脂肪性肝病患者肝脏脂肪变的早期驱动因子”（2022BC158），2023.06-2024.05，

◆ 科研成果

1. Fu J, Liu C, Yang L, Zhang B, Zhou R, Deng C, Zhang H, Kong J, Li J, Shi J. Effect of high-intensity interval training on clinical parameters in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials. Eur J Gastroenterol Hepatol. 2025 Mar 7.

2. Song Y, Ni W, Zheng M, Sheng H, Wang J, Xie S, Yang Y, Chi X, Chen J, He F, Fan X, Mi Y, Zhang J, Wang B, Bai L, Xie W, Zhong B, Yeo YH, Rui F, Zang S, Li J, Shi J; Chinese NAFLD Clinical Research Network (CNAFLD CRN). Vitamin E (300 mg) in the treatment of MASH: A multi-center, randomized, double-blind, placebo-controlled study. Cell Rep Med. 2025 Feb 18;6(2):101939.

3. Shao L, Zhang B, Song Y, Lyu Z, Zhang W, Yang W, Fu J, Li J, Shi J. Mucosal Hub Bacteria as Potential Targets for Improving High-Fat Diet-Related Intestinal Barrier Injury. Can J Infect Dis Med Microbiol. 2024 Nov 27;2024:3652740.

4. Liu C, Zhou R, Shi J. How to Enhance Adherence in Patients with Nonalcoholic Fatty Liver Disease: A Thought-Provoking Issue. J Med Internet Res. 2024 May 14;26:e59208.

5. Peng D, Zhuge F, Wang M, Zhang B, Zhuang Z, Zhou R, Zhang Y, Li J, Yu Z, Shi J. Morus alba L. (Sangzhi) alkaloids mitigate atherosclerosis by regulating M1/M2 macrophage polarization. Phytomedicine. 2024 Mar 11;128:155526.

6. Zhou R, Zhang B, Zhang W, Kong T, Fu J, Li J, Shi J. Self-management behaviours in adults with non-alcoholic fatty liver disease: a cross-sectional survey from China. BMJ Open. 2024 Feb 22;14(2):e078333.

7. Zhao B, Zhang J, Zhao K, Zhao W, Shi Y, Liu J, Zeng L, Wang C, Zeng X, Shi J. Study on the mechanism of vitamin E alleviating non-alcoholic fatty liver function based on non-targeted metabolomics analysis in rats. Naunyn Schmiedebergs Arch Pharmacol. 2023 Dec 13.

8. Yeo YH, Zhu Y, Arab JP, Ni W, Xu X, Shi J, Li J. Alcohol Intake Thresholds Among Individuals With Steatotic Liver Disease. JAMA Netw Open. 2023 Dec 1;6(12):e2347548.

9. Liu J, Zhang H, Kong J, Liu S, Chen L, Jiang Y, Wang J, Zhang B, Ye X, Gong L, Zhou X, Chen G, Li J, Pan X, Zhang H, Shi J. Alleviated symptoms of SARS-CoV-2 Omicron variant infection in chronic hepatitis B patients with immune control. J Med Virol. 2023 Oct;95(10):e29173.

10. Wang Y, Zhu Q, Sun R, Yi X, Huang L, Hu Y, Ge W, Gao H, Ye X, Song Y, Shao L, Li Y, Li J, Guo T, Shi J. Longitudinal proteomic investigation of COVID-19 vaccination. Protein Cell. 2023 Sep 14;14(9):668-682.